Media Thread, page-5401

Wasa,

I have not nor will I put @fourdollars on ignore. He has his opinions, I don’t have to agree with him, but he’s not rude & HER-VAXX is his ‘bug bear’ & has been for a long time. When a poster signs off with Peace, I’m sure they mean it . It’s time consuming answering these posts, however time is not infinite in our lives. So I don’t see the point really continuing on a broken record on repeat. It’s both boring & draining.

This discussion & what @davybabyk answered some time ago also, has been going on for a long time now, well basically since the Interim data came out, so it’s a bit like GroundHog day lol.

So now I’m just going to wait until final Her-Vaxx Ph2 data is announced & bearing in mind this patient cohort were Stage 4 GEJ with the Primary Endpoint being OS.
I actually think it’s prolonged from what even IMU were expecting.

Bioshares Slides link, for you @fourdollars. I would have thought that you would have seen that IMU were presenting there & were aware of this conference being a Biotech investor (people have posted links on the board).

https://www.imugene.com/investor-presentations

Apologies if you didn’t know about the Bioshares Annual Event. A lot has been disrupted due to COVID in the last few years. Good to see things are getting back to F2F for conferences.

Have a lovely weekend all.